ALTUS BIOLOGICS, INC.

Company Information

Company Name
ALTUS BIOLOGICS, INC.
Address
ALTUS BIOLOGICS, INC.
625 PUTNAM AVE
CAMBRIDGE, MA, 02139 0480
Phone
1 617-299-2971
URL
n/a
DUNS
n/a
Number of Employees
n/a

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$701,807.00
9
SBIR Phase II
$1,995,476.00
3
Chart code to be here

Award List

  1. Dehydrogenase Crystals as Catalysts in Organic Synthesis

    Amount: $495,146.00

    Enzyme microcrystals (less than 100 um) grown from aqueous solution and cross-linked witha bifunctional agent such as glutaraldehyde exhibit remarkable characteristics that are superior to bothsoluble ...

    SBIR Phase II 1996 Department of Health and Human Services
  2. N/A

    Amount: $750,000.00

    N/A

    SBIR Phase II 1999 Department of Health and Human Services
  3. N/A

    Amount: $100,000.00

    N/A

    SBIR Phase I 1999 National Science Foundation
  4. PROTEASE FORMULATION BASED ON CROSSLINKED ENZYME CRYSTAL

    Amount: $100,083.00

    Design of new efficient drug delivery systems for proteins is one of the major themes of modern biotechnology and biopharmaceutical industry. We found that crosslinked enzyme crystals (CLECs(R)) show ...

    SBIR Phase I 2001 Department of Health and Human Services
  5. NOVEL ENZYME FORMULATION FOR TREATMENT OF HYPEROXALURIA

    Amount: $86,724.00

    DESCRIPTION (provided by applicant): Design of new efficient drug delivery systems for proteins is one of the major themes of modern biotechnology and biopharmaceutical industry. We ...

    SBIR Phase I 2001 Department of Health and Human Services
  6. PREVENTION OF BIOFILMS IN MEDICAL DEVICES

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Design of new efficient drug delivery systems for proteins is one of the major themes of modern biotechnology and biopharmaceutical industry. We found that cross-l ...

    SBIR Phase I 2003 Department of Health and Human Services
  7. NOVEL PROTEASE FORMULATION BASED ON CROSSLINKED CRYSTALS

    Amount: $0.00

    DESCRIPTION (provided by applicant): Design of stable and efficient formulation of proteins for therapeutic use as drugs has been a major focus of biotechnology and pharmaceutical companies. In the P ...

    SBIR Phase I 2003 Department of Health and Human Services
  8. NOVEL PROTEASE FORMULATION BASED ON CROSSLINKED CRYSTALS

    Amount: $750,330.00

    DESCRIPTION (provided by applicant): Design of stable and efficient formulation of proteins for therapeutic use as drugs has been a major focus of biotechnology and pharmaceutical companies. In the P ...

    SBIR Phase II 2003 Department of Health and Human Services
  9. SBIR Phase I: Protein Crystals as Novel Materials for Chromatography

    Amount: $75,000.00

    N/A

    SBIR Phase I 1997 National Science Foundation
  10. PROTEIN DRUG DELIVERY BASED ON STABILIZED PROTEIN

    Amount: $100,000.00

    N/A

    SBIR Phase I 1997 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government